Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Abstract
Objective: There is substantial evidence supporting the role of interferon (IFN)‐γ–producing T helper (T H ) 1 and interleukin (IL)‐17–expressing T H 17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN‐γ–expressing T H 17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). Methods: Human T H 17 lymphocytes were expanded in vitro from the blood of healthy controls and relapsing MS patients using IL‐23. Immune cell migration to the CNS was assessed in vitro with primary cultures of human blood–brain barrier (BBB)‐derived endothelial cells, and in vivo in EAE mice. Results: We demonstrate that in response to IL‐23, human memory lymphocytes expand into a T H 17 phenotype, with a subpopulation of cells simultaneously expressing IFN‐γ and IL‐17. We note that lymphocytes obtained from the blood of relapsing MS patients have an increased propensity to expand into IFN‐γ–producing T H 17 cells and identify numerous T lymphocytes coexpressing IL‐17 and IFN‐γ in brain tissue of MS patients. We also find lymphocytes expressing both the T H 1‐ and the T H 17‐associated transcription factors RORγt and T‐bet, in situ and in vitro. We further provide in vitro and in vivo evidence that IFN‐γ + T H 17 lymphocytes preferentially cross the human BBB and accumulate in the CNS of mice during the effector phase of EAE. Interpretation: Our data underscore the involvement of IFN‐γ + T H 17 lymphocytes in the pathology of MS and EAE and their preferential recruitment into the CNS during inflammatory events. Ann Neurol 2009;66:390–402
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies show a protective function for IL-17A in colitis, possibly by promoting intestinal epithelial barrier integrity.
“In fact, some studies show a protective function for IL-17A in colitis [128, 129], possibly due to the role of IL-17A in promoting intestinal epithelial barrier integrity [130].”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [128]
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145 · see citing works
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · see citing works
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · see citing works
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · see citing works
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · see citing works
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · see citing works
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · see citing works
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149 · see citing works
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861 · see citing works
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · see citing works
Self-citationIL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536 · see citing works
Immune cell migration in inflammation: present and future therapeutic targets
Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313 · see citing works
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,285 · see citing works
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,180 · see citing works
Ferber, I., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. (1996) · Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 1,088 · see citing works
Late Developmental Plasticity in the T Helper 17 Lineage
Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.005 · Cited by 1,053 · see citing works
The IL-23/IL-17 axis in inflammation
Iwakura, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28508 · Cited by 1,046 · see citing works
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951 · see citing works
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · see citing works
Understanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 761 · see citing works
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733 · see citing works
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 580 · see citing works
Boniface, K., Bak‐Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & Malefyt, R. D. W. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 474 · see citing works
Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444 · see citing works
Self-citationEid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A. E., Sokol, S. I., Pfau, S. E., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 413 · see citing works
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., & Waisman, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35997 · Cited by 398 · see citing works
Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L., Renauld, J., & Becher, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8098 · Cited by 330 · see citing works
Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., & Hofman, F. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.574 · Cited by 297 · see citing works
Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease
Weiner, H. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1613 · Cited by 295 · see citing works
Glial cell influence on the human blood‐brain barrier
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 269 · see citing works
Self-citationVaknin‐Dembinsky, A., Balashov, K. E., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7768 · Cited by 257 · see citing works
Ifergan, I., Kébir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R., Arbour, N., & Prat, A. (2007) · Brain · doi:10.1093/brain/awm295 · Cited by 198 · see citing works
Self-citationOpposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
Friese, M. A., Jakobsen, K. B., Friis, L. S., Etzensperger, R., Craner, M. J., McMahon, R. M., Jensen, L. T., Huygelen, V., Jones, E. Y., Bell, J. I., et al. (2008) · Nature Medicine · doi:10.1038/nm.1881 · Cited by 184 · see citing works
Silencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes
Lovett‐Racke, A. E., Rocchini, A., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D. S., & Racke, M. K. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.010 · Cited by 183 · see citing works
Bö, L., Peterson, J. W., Mørk, S. J., Hoffman, P. A., Gallatin, M. W., Ransohoff, R. M., & Trapp, B. D. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199655100-00006 · Cited by 144 · see citing works
Regulation of Th1 and Th2 Lymphocyte Migration by Human Adult Brain Endothelial Cells
Biernacki, K., Prat, A., Blain, M., & Antel, J. P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1127 · Cited by 88 · see citing works
Self-citationRenno, T., Zeine, R. R., Girard, J. M., Glllani, S., Dodelet, V. C., & Owens, T. (1994) · International Immunology · doi:10.1093/intimm/6.3.347 · Cited by 64 · see citing works
Good for Goose, but Not for Gander: IL-2 Interferes with Th17 Differentiation
Stockinger, B. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.001 · Cited by 40 · see citing works
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Flagged first, then by citations
Cited by
Sorted by citations
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215 · see citing works
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · see citing works
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562 · see citing works
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388 · see citing works
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289 · see citing works
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate‐Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,155 · see citing works
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. J., & Mills, K. H. G. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 937 · see citing works
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., Sabbagh, M., Wosik, K., Bourbonnière, L., Bernard, M., et al. (2011) · Science · doi:10.1126/science.1206936 · Cited by 845 · see citing works
Self-citationModulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Ghoreschi, K., Jesson, M. I., Xiong, L., Lee, J. L., Ghosh, S., Alsup, J. W., Warner, J. D., Tanaka, M., Steward-Tharp, S. M., Gadina, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003668 · Cited by 642 · see citing works
Glial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 542 · see citing works
Self-citationRamesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 434 · see citing works
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 439 · see citing works
Qiu, J., Guo, X., Chen, Z. E., He, L., Sonnenberg, G. F., Artis, D., Fu, Y., & Zhou, L. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.002 · Cited by 415 · see citing works
Androgen-Induced Immunosuppression
Bupp, M. G., & Jørgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 393 · see citing works
Animal models of Multiple Sclerosis
Procaccini, C., Rosa, V. D., Pucino, V., Formisano, L., & Matarese, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.042 · Cited by 371 · see citing works
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming
Roy, D. G., Chen, J., Mamane, V. H., Ma, E. H., Muhire, B. M., Sheldon, R. D., Shorstova, T., Koning, R., Johnson, R. M., Esaulova, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.006 · Cited by 347 · see citing works
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334 · see citing works
Self-citationWeber, M. S., Prod’homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 321 · see citing works
Effector T Cells in Multiple SclerosisPreprint
Kaskow, B. J., & Baecher‐Allan, C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029025 · Cited by 314 · see citing works
Effect of IL-17A blockade with secukinumab in autoimmune diseases
Patel, D. D., Lee, D. M., Kolbinger, F., & Antoni, C. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202371 · Cited by 311 · see citing works
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Moser, T., Akgün, K., Proschmann, U., Sellner, J., & Ziemssen, T. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102647 · Cited by 307 · see citing works
Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003952 · Cited by 289 · see citing works
TH17 cell heterogeneity and its role in tissue inflammation
Schnell, A., Littman, D. R., & Kuchroo, V. K. (2023) · Nature Immunology · doi:10.1038/s41590-022-01387-9 · Cited by 286 · see citing works
A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
Stadhouders, R., Lubberts, E., & Hendriks, R. W. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.007 · Cited by 289 · see citing works
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 286 · see citing works
T cell responses in the central nervous system
Korn, T., & Kallies, A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.144 · Cited by 268 · see citing works
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity
Schnell, A., Huang, L., Singer, M., Singaraju, A., Barilla, R. M., Regan, B. M. L., Bollhagen, A., Thakore, P. I., Dionne, D., Delorey, T. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.018 · Cited by 268 · see citing works
Th17 Cell Plasticity and Functions in Cancer Immunity
Guéry, L., & Hugues, S. (2015) · BioMed Research International · doi:10.1155/2015/314620 · Cited by 262 · see citing works
Interleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250 · see citing works
Lazarevic, V., & Glimcher, L. H. (2011) · Nature Immunology · doi:10.1038/ni.2059 · Cited by 248 · see citing works
Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
Glatigny, S., & Bettelli, E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028977 · Cited by 247 · see citing works
Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M. C., Hemmer, B., & Korn, T. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110434 · Cited by 242 · see citing works
Ramstein, J., Broos, C. E., Simpson, L. J., Ansel, K. M., Sun, S. A., Ho, M. E., Woodruff, P. G., Bhakta, N. R., Christian, L., Nguyen, C. P., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1499oc · Cited by 260 · see citing works
Th17 Response and Inflammatory Autoimmune Diseases
Waite, J. C., & Skokos, D. (2011) · International Journal of Inflammation · doi:10.1155/2012/819467 · Cited by 239 · see citing works
Greenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., & Engelhardt, B. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01140.x · Cited by 240 · see citing works
Self-citationT Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Kunkl, M., Frascolla, S., Amormino, C., Volpe, E., & Tuosto, L. (2020) · Cells · doi:10.3390/cells9020482 · Cited by 232 · see citing works
Memory CD4+ T Cells in Immunity and Autoimmune Diseases
Raphael, I., Robinson, R. R., & Forsthuber, T. G. (2020) · Cells · doi:10.3390/cells9030531 · Cited by 232 · see citing works
van Langelaar, J., de Vries, R. M. V. D. V., Janssen, M., Wierenga‐Wolf, A. F., Spilt, I. M., Siepman, T. A. M., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 224 · see citing works
Zhang, M. A., Rego, D., Moshkova, M., Kébir, H., Chruscinski, A. J., Nguyen, H. T., Akkermann, R., Stanczyk, F. Z., Prat, A., Steinman, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118458109 · Cited by 216 · see citing works
Self-citationCD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Annibali, V., Ristori, G., Angelini, D. F., Serafini, B., Mechelli, R., Cannoni, S., Romano, S., Paolillo, A., Abderrahim, H., Diamantini, A., et al. (2011) · Brain · doi:10.1093/brain/awq354 · Cited by 213 · see citing works
Wang, Y., Godec, J., Ben-Aissa, K., Cui, K., Zhao, K., Pucsek, A. B., Lee, Y. K., Weaver, C. T., Yagi, R., & Lazarevic, V. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.002 · Cited by 206 · see citing works
T helper 17 cell heterogeneity and pathogenicity in autoimmune disease
Ghoreschi, K., Laurence, A. D. J., Yang, X., Hirahara, K., & O’Shea, J. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.007 · Cited by 205 · see citing works
A basic overview of multiple sclerosis immunopathology
Grigoriadis, N., & Pesch, V. V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 204 · see citing works
Th1 Versus Th17: Are T Cell Cytokines Relevant in Multiple Sclerosis?
Lovett-Racke, A., Yang, Y.-H., & Racke, M. (2010) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2010.05.012 · Cited by 223 · see citing works
Pivotal Roles of GM‐CSF in Autoimmunity and Inflammation
Shiomi, A., & Usui, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/568543 · Cited by 200 · see citing works
Multiple Sclerosis and T Lymphocytes: An Entangled Story
Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 196 · see citing works
Self-citationA role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
Kamali, A. N., Noorbakhsh, S. M., Hamedifar, H., Jadidi‐Niaragh, F., Yazdani, R., Bautista, J. M., & Azizi, G. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.11.015 · Cited by 193 · see citing works
Naringenin: A flavanone with anti-inflammatory and anti-infective properties
Ji, C., Wen, H., Zhou, H., Zhang, D., Lan, D., Liu, S., Li, C., Dai, X., Song, T., Wang, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114990 · Cited by 197 · see citing works
T‐cell trafficking in the central nervous system
Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A., & Engelhardt, B. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01140.x · Cited by 186 · see citing works
Boniface, K., Blumenschein, W. M., Brovont-Porth, K., McGeachy, M. J., Basham, B., Desai, B., Pierce, R. H., McClanahan, T. K., Sadekova, S., & Malefyt, R. D. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000366 · Cited by 188 · see citing works
van Hamburg, J. P., & Tas, S. W. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.006 · Cited by 186 · see citing works
Inflammation in multiple sclerosis
Haase, S., & Linker, R. A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211007687 · Cited by 191 · see citing works
Chambers, E. S., Nanzer, A. M., Pfeffer, P., Richards, D. F., Timms, P. M., Martineau, A. R., Griffiths, C., Corrigan, C. J., & Hawrylowicz, C. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.026 · Cited by 181 · see citing works
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 176 · see citing works
Cutting Edge: The Pathogenicity of IFN-γ–Producing Th17 Cells Is Independent of T-bet
Duhen, R., Glatigny, S., Arbelaez, C. A., Blair, T. C., Oukka, M., & Bettelli, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203172 · Cited by 169 · see citing works
Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells
Jain, R., Chen, Y., Kanno, Y., Joyce-Shaikh, B., Vahedi, G., Hirahara, K., Blumenschein, W. M., Sukumar, S., Haines, C. J., Sadekova, S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.009 · Cited by 167 · see citing works
Role of ninjurin‐1 in the migration of myeloid cells to central nervous system inflammatory lesions
Ifergan, I., Kébir, H., Terouz, S., Alvarez, J. I., Lécuyer, M., Gendron, S., Bourbonnière, L., Dunay, I. R., Bouthillier, A., Moumdjian, R. A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22519 · Cited by 167 · see citing works
Self-citationChang, J., Cha, H., Lee, D., Seo, K. Y., & Kweon, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012925 · Cited by 166 · see citing works
Advances in the immunopathogenesis of multiple sclerosis
Yadav, S. K., Mindur, J. E., Ito, K., & Dhib-Jalbut, S. S. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000205 · Cited by 166 · see citing works
IFN‐γ and IL‐12 synergize to convert in vivo generated Th17 into Th1/Th17 cells
Lexberg, M. H., Taubner, A., Albrecht, I., Lepenies, I., Richter, A., Kamradt, T., Radbruch, A., & Chang, H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040539 · Cited by 162 · see citing works
Basdeo, S. A., Cluxton, D., Sulaimani, J., Moran, B., Canavan, M., Orr, C. K., Veale, D. J., Fearon, U., & Fletcher, J. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600737 · Cited by 156 · see citing works
Jurado, J. O., Pasquinelli, V., Alvarez, I. B., Peña, D., Rovetta, A. I., Tateosian, N. L., Romeo, H. E., Musella, R. M., Palmero, D., Chuluyán, E., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211619 · Cited by 161 · see citing works
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
Хайбуллин, Т. И., Ivanova, V. V., Martynova, E. V., Черепнев, Г. В., Хабиров, Ф. А., Granatov, E. V., Rizvanov, A. A., & Khaiboullina, S. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00531 · Cited by 161 · see citing works
The Immunology of Multiple Sclerosis
Bar‐Or, A. (2008) · Seminars in Neurology · doi:10.1055/s-2007-1019124 · Cited by 153 · see citing works
Granuloma Formation in Pulmonary Sarcoidosis
Broos, C. E., van Nimwegen, M., Hoogsteden, H. C., Hendriks, R. W., Kool, M., & van den Blink, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00437 · Cited by 156 · see citing works
Darlington, P. J., Touil, T., Doucet, J.-S., Gaucher, D., Zeidan, J., Gauchat, D., Corsini, R., Kim, H. J., Duddy, M., Jalili, F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23784 · Cited by 151 · see citing works
Self-citationKann, O., Almouhanna, F., & Chausse, B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.10.007 · Cited by 150 · see citing works
Velde, C. V., McDonald, K. K., Boukhedimi, Y., McAlonis‐Downes, M., Lobsiger, C. S., Hadj, S. B., Zandona, A., Julien, J., Shah, S. B., & Cleveland, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022031 · Cited by 150 · see citing works
Immunopathogenesis of multiple sclerosis
Comabella, M., & Khoury, S. J. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.03.004 · Cited by 147 · see citing works
dos Passos, G. R., Sato, D. K., Becker, J., & Fujihara, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/5314541 · Cited by 149 · see citing works
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Wang, J., Xu, Y., Chen, Z., Liang, J., Lin, Z., Liang, H., Xu, Y., Wu, Q., Guo, X., Nie, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.048 · Cited by 147 · see citing works
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020) · Cells · doi:10.3390/cells9010110 · Cited by 143 · see citing works
Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain · doi:10.1093/brain/aws212 · Cited by 145 · see citing works
Self-citationBrown, C. C., Esterházy, D., Sarde, A., London, M., Pullabhatla, V., Osma-García, I. C., al-Bader, R., Ortiz, C., Elgueta, R., Arno, M. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.003 · Cited by 143 · see citing works
Brockmann, L., Giannou, A. D., Gagliani, N., & Huber, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051033 · Cited by 143 · see citing works
JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation
Carr, T. M., Wheaton, J. D., Houtz, G. M., & Ciofani, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00380-3 · Cited by 141 · see citing works
TH17 cytokines in autoimmune neuro-inflammation
Becher, B., & Segal, B. M. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.005 · Cited by 142 · see citing works
Gao, H., Danzi, M. C., Choi, C. S., Taherian, M., Hansen, C. D., Ellman, D. G., Madsen, P. M., Bixby, J. L., Lemmon, V., Lambertsen, K. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.11.083 · Cited by 136 · see citing works
Hu, D., Notarbartolo, S., Croonenborghs, T., Patel, B., Cialic, R., Yang, T.-H., Aschenbrenner, D., Andersson, K., Gattorno, M., Pham, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01571-8 · Cited by 138 · see citing works
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136 · see citing works
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
Wu, D., Wang, J., Pae, M., & Meydani, S. N. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.001 · Cited by 137 · see citing works
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
Machhi, J., Kevadiya, B. D., Muhammad, I. K., Herskovitz, J., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00375-7 · Cited by 136 · see citing works
Luchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 133 · see citing works
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Sweeney, C. M., Lonergan, R. M., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J., Costelloe, L., Tubridy, N. J., Mills, K. H. G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.007 · Cited by 133 · see citing works
Wiśniewski, J., Muehling, L. M., Eccles, J. D., Capaldo, B. J., Agrawal, R., Shirley, D.-A. T., Patrie, J. T., Workman, L. J., Schuyler, A. J., Lawrence, M. G., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.020 · Cited by 131 · see citing works
Ifergan, I., Kébir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonnière, L., Poirier, J., Duquette, P., Talbot, P. J., Arbour, N., et al. (2011) · Brain · doi:10.1093/brain/awr268 · Cited by 129 · see citing works
Self-citationDuhen, T., & Campbell, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302734 · Cited by 129 · see citing works
Intrinsic blood–brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Nishihara, H., Perriot, S., Gastfriend, B. D., Steinfort, M., Cibien, C., Soldati, S. G., Matsuo, K., Guimbal, S., Mathias, A., Palecek, S. P., et al. (2022) · Brain · doi:10.1093/brain/awac019 · Cited by 129 · see citing works
Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
McGinley, A. M., Edwards, S. C., Raverdeau, M., & Mills, K. H. G. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.01.001 · Cited by 127 · see citing works
Pathogenic T cell cytokines in multiple sclerosis
Wagner, C. A., Roqué, P. J., & Goverman, J. M. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190460 · Cited by 123 · see citing works
Regué, D. R., Grau‐López, L., Naranjo‐Gómez, M., Ramo-Tello, C. M., Pujol‐Borrell, R., Martínez-Cáceres, E. M., & Borràs, F. E. (2012) · European Journal of Immunology · doi:10.1002/eji.201141835 · Cited by 120 · see citing works
Inflammasome-Derived IL-1β Regulates the Production of GM-CSF by CD4+ T Cells and γδ T Cells
Lukens, J. R., Barr, M., Chaplin, D., Chi, H., & Kanneganti, T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103308 · Cited by 117 · see citing works
Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis
Chuluundorj, D., Harding, S. A., Abernethy, D. A., & Flamme, A. C. L. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.15 · Cited by 116 · see citing works
Seeing through the dark: New insights into the immune regulatory functions of vitamin A
Brown, C. C., & Noelle, R. J. (2015) · European Journal of Immunology · doi:10.1002/eji.201344398 · Cited by 116 · see citing works
Nishihara, H., Soldati, S. G., Mossu, A., Rosito, M., Rudolph, H., Müller, W. A., Latorre, D., Sallusto, F., Sospedra, M., Martinꝉ, R., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0165-2 · Cited by 114 · see citing works
Bălașa, R., Bărcuţean, L., Bălașa, A. F., Moțățăianu, A., Roman-Filip, C., & Manu, D. R. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 111 · see citing works
Dietel, B., Cicha, I., Voskens, C., Verhoeven, E. L. G., Achenbach, S. S., & Garlichs, C. D. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.014 · Cited by 109 · see citing works
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren‐Wiemers, N., & Pasquier, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 107 · see citing works
The role of Th17 cells in auto-inflammatory neurological disorders
Tahmasebinia, F., & Pourgholaminejad, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.023 · Cited by 105 · see citing works
Chemokines and Chemokine Receptors in Multiple Sclerosis
Cheng, W., & Chen, G. (2014) · Mediators of Inflammation · doi:10.1155/2014/659206 · Cited by 106 · see citing works
- Authors
- Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A.
- Affiliations
- Hôpital Notre-Dame (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 66
- Issue
- 3
- Pages
- 390-402
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2127568644
- Cited by
- 551
- References
- 39
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 36 · 2022: 34 · 2021: 38 · 2020: 27 · 2019: 35 · 2018: 34 · 2017: 40 · 2016: 37 · 2015: 47 · 2014: 42 · 2013: 36 · 2012: 29
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- multiple sclerosis, experimental autoimmune encephalomyelitis, Th17 cells, interferon-gamma, IL-17, IL-23, blood-brain barrier, T-bet, memory T cells, relapsing multiple sclerosis
- MeSH terms
- Adult, Animals, Blood-Brain Barrier, Brain, Cell Migration Inhibition, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Interferon-gamma, Mice, Inbred C57BL, Middle Aged, Multiple Sclerosis, T-Lymphocytes, Th1 Cells, Th2 Cells, Interleukin-17, Multiple Sclerosis, Relapsing-Remitting, Mice, Interleukin-23, Cell Migration Assays, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
